The report’s highlight is that SARS-CoV-2 possibly emerged from a laboratory leak. The report found this conclusion on ...

The House Select Subcommittee on the Coronavirus Pandemic recently issued its final After Action Review of the COVID-19 ...

Previously, he was Global Devlopment Unit Head for Immunology, Hepatology and Dermatology at Novartis and held several executive and senior positions at Bristol Myers Squibb, including Head of ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, ...

Berger specialized in cancer long before joining Genentech, holding oncology global clinical development roles at Amgen and ...

Researchers discovered a vulnerability in viral enzymes that could lead to novel treatments for diseases as diverse as COVID-19 and Ebola -- while also minimizing side effects and reducing the odds of ...

Everyone knows there’s no cure for the common cold. Though colds can strike at any time, cold season tends to occur when the ...

Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent ...

In his new role, Berger will oversee Gilead’s Global Development and Medical Affairs organisations and lead the company’s ...

Highly pathogenic avian influenza has been found in samples taken from snow geese at Sloughs Wildlife Management Area (WMA) ...

Gilead Sciences, Inc. has announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical ...